SAIAMA WAQAR, MD

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

Administration of chemotherapy into vein, 1 hour or less

New patient office or other outpatient visit, 60-74 minutes

Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes

Red blood cells, leukocytes reduced, irradiated, each unit

Established patient office or other outpatient visit, 40-54 minutes

Administration of additional new drug or substance into vein, 1 hour or less

Established patient office or other outpatient visit, 30-39 minutes

Transfusion of blood or blood products

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Infusion into a vein for hydration, 31-60 minutes

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Administration of chemotherapy into vein, each additional hour

Established patient office or other outpatient visit, 20-29 minutes

Injection of additional new drug or substance into vein

Infusion into a vein for hydration, each additional hour

Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

Injection of drug or substance under skin or into muscle

Injection, palonosetron hcl, 25 mcg

Injection, paclitaxel protein-bound particles, 1 mg

Insertion of needle into vein for collection of blood sample

Infusion, normal saline solution , 1000 cc

Injection, fluorouracil, 500 mg

Injection, leucovorin calcium, per 50 mg

Injection, granisetron hydrochloride, 100 mcg

Injection, fosaprepitant, 1 mg

Injection, dexamethasone sodium phosphate, 1 mg